Purple Biotech Ltd.
Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.
What’s moving Purple Biotech Ltd. now
Current reporting with the operating signal separated from the noise.
Purple Biotech Ltd. Sponsored ADR
The story matters when it changes Purple Biotech Ltd.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Purple Biotech Ltd. Reports Final CM24 Phase 2 Data at AACR Annual Meeting 2025, Updates on NT219 and CAPTN-3 Platforms
The story matters when it changes Purple Biotech Ltd.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Latest PPBT filings.
Investor-relevant reports are shown first, followed by the company’s other recent official submissions.
Purple Biotech Ltd., quarter by quarter.
Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.
First quarter
No verified period-specific item in the current feed.
SEARCH Q1 COVERAGE →Second quarter
No verified period-specific item in the current feed.
SEARCH Q2 COVERAGE →Third quarter
No verified period-specific item in the current feed.
SEARCH Q3 COVERAGE →Fourth quarter / full year
No verified period-specific item in the current feed.
SEARCH Q4 COVERAGE →